DHS Opioid Detection Resilience Act of 2019

United States116th CongressHR-4761House of Representatives
Updated: Dec 23, 2020

Summary

DHS Opioid Detection Resilience Act of 2019 This bill establishes new requirements related to the detection of illicit narcotics at ports of entry. Specifically, U.S. Customs and Border Protection (CBP) must implement a strategy to ensure chemical screening devices are able to identify narcotics at purity levels equal to or less than 10%, or provide an alternate method for identifying narcotics at lower purity levels. The CBP must also test new chemical screening devices at various purity levels before it commits to their acquisition. Additionally, the Department of Homeland Security must implement a plan for the long-term development of a centralized spectral database for chemical screening devices.

Bill texts

Available versions
View official text

3 versions available

Timeline

Latest companion bill action

S-3250: DHS Opioid Detection Resilience Act of 2020

Read twice and referred to the Committee on Homeland Security and Governmental Affairs.

  1. Message on Senate action sent to the House.

    Senate

  2. Presented to President.

    House of Representatives

  3. Became Public Law No: 116-254.

  4. Signed by President.